Tim Ward
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 8
- Oncology top 1%
- Cancer Cells and Metastasis 8
- Lung Cancer Research Studies 4
-
- Lung Cancer Treatments and Mutations 6
- Biotechnology top 5%
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 7
- Cell death mechanisms and regulation 4
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Bioactive Compounds and Antitumor Agents 3
- Co-authors
- Caroline DiveFiona BlackhallMatthew KrebsRobert Szczepaniak‐SloaneLynsey PriestMalcolm RansonLee LancashireAndrew Hughes
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Thoracic Oncology (4 papers)Journal of Immunological Methods (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Tim Ward
39 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 1.5k
- Oncology 2.4k
- Pulmonary and Respiratory Medicine 1.0k
- Biotechnology 155
- Molecular Biology 1000
Countries citing papers authored by Tim Ward
This map shows the geographic impact of Tim Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Ward more than expected).
Fields of papers citing papers by Tim Ward
This network shows the impact of papers produced by Tim Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Ward. The network helps show where Tim Ward may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tim Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 5 | |
| 2 | 2013 | 23 | |
| 3 | 2011 | 343 | |
| 4 | 2011 | 26 | |
| 5 | 2011 | 371 | |
| 6 | 2011 | 38 | |
| 7 | 2010 | 40 | |
| 8 | 2010 | 36 | |
| 9 | 2010 | 25 | |
| 10 | 2009 | 29 | |
| 11 | 2009 | 189 | |
| 12 | 2008 | 46 | |
| 13 | Cell death ELISAs in the phase I clinical evaluation of AEG35156 (XIAP antisense) administered as an intravenous infusion over 7-days, 3-days, and 2-hours. | 2007 | 0 |
| 14 | 2007 | 90 | |
| 15 | AEG35156, a XIAP antisense oligonucleotide, suppresses XIAP levels in targeted tissues isolated from pre-clinical models and from patients | 2006 | 3 |
| 16 | 2006 | 41 | |
| 17 | 2004 | 65 | |
| 18 | 2002 | 27 | |
| 19 | 2000 | 37 | |
| 20 | 1995 | 6 |
About Tim Ward
Tim Ward is a scholar working on Toxicology, Cancer Research and Oncology, having authored 40 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), Cancer Genomics and Diagnostics (8 papers), Cancer therapeutics and mechanisms (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cell death mechanisms and regulation (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Lung Cancer Research Studies (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (2.4k citations) and Pulmonary and Respiratory Medicine (1.0k citations). Tim Ward has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Caroline Dive, Fiona Blackhall, Matthew Krebs, Robert Szczepaniak‐Sloane, Lynsey Priest, Malcolm Ranson, Lee Lancashire, Andrew Hughes, Alastair Greystoke and Glen Clack. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Journal of Immunological Methods, Molecular Cancer Therapeutics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.